Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Polo-like kinases and acute leukemia.

Goroshchuk O, Kolosenko I, Vidarsdottir L, Azimi A, Palm-Apergi C.

Oncogene. 2018 Aug 13. doi: 10.1038/s41388-018-0443-5. [Epub ahead of print] Review.

PMID:
30104712
2.

The molecular dynamics of long noncoding RNA control of transcription in PTEN and its pseudogene.

Lister N, Shevchenko G, Walshe JL, Groen J, Johnsson P, Vidarsdóttir L, Grander D, Ataide SF, Morris KV.

Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):9942-9947. doi: 10.1073/pnas.1621490114. Epub 2017 Aug 28.

3.

A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells.

Johnsson P, Ackley A, Vidarsdottir L, Lui WO, Corcoran M, Grandér D, Morris KV.

Nat Struct Mol Biol. 2013 Apr;20(4):440-6. doi: 10.1038/nsmb.2516. Epub 2013 Feb 24.

4.

Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition.

Vidarsdottir L, Steingrimsdottir G, Bodvarsdottir SK, Ogmundsdottir HM, Eyfjord JE.

Invest New Drugs. 2012 Apr;30(2):425-34. doi: 10.1007/s10637-010-9566-4. Epub 2010 Oct 20.

PMID:
20960027
5.

AURKA and breast cancer in BRCA1/2 mutation carriers.

Bodvarsdottir SK, Vidarsdottir L, Eyfjord JE.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2517. No abstract available.

6.

Prostate cancer progression and survival in BRCA2 mutation carriers.

Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, Jonasson JG, Olafsdóttir EJ, Olafsdóttir GH, Rafnar T, Thorlacius S, Jonsson E, Eyfjord JE, Tulinius H.

J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. Epub 2007 Jun 12.

PMID:
17565157
7.

Breast cancer risk associated with AURKA 91T -->A polymorphism in relation to BRCA mutations.

Vidarsdottir L, Bodvarsdottir SK, Hilmarsdottir H, Tryggvadottir L, Eyfjord JE.

Cancer Lett. 2007 Jun 8;250(2):206-12. Epub 2006 Nov 17.

PMID:
17113223

Supplemental Content

Loading ...
Support Center